Dissolution Test for Tablets and Capsules: Complete Guide

Not all tablets and capsules work the same way once they are taken. Some release their active ingredient quickly, while others are designed to release it slowly over time. What matters is how effectively it becomes available in the body.

That is exactly what the dissolution test for tablets and capsules is designed to measure. This test plays a crucial role in pharmaceutical manufacturing.

Below, we will explain what the dissolution test for tablets is, how it works, and why it matters for regulatory compliance. This guide also highlights common testing challenges manufacturers face and how to address them.

What Is a Dissolution Test for Tablets and Capsules?

A dissolution test for tablets and capsules is defined as the process of measuring the rate and extent to which an активный фармацевтический ингредиент (АФИ) dissolves from a tablet or capsule into a solution.

It is a laboratory procedure used to measure how quickly and how much of a drug is released from its лекарственная форма into a liquid medium. This test is carried out under controlled conditions that mimic the human digestive environment.

It is a key part of pharmaceutical quality control and is required by regulatory bodies such as the U.S. Food and Drug Administration and pharmacopeias like the United States Pharmacopeia.

How the Dissolution Test for Tablets and Capsules Works

Here’s a step-by-step guide on how the dissolution test works for tablets and capsules.

Step 1: Prepare the Dissolution Medium

The process begins with preparing the correct dissolution medium. This liquid is selected based on the drug and is designed to mimic body fluids. It could be purified water, a buffer solution, or a simulated gastric fluid.

The medium must be measured accurately and adjusted to the required pH. In some cases, it is also degassed to remove air bubbles that could interfere with the test. If the medium is not prepared correctly, the entire test becomes unreliable.

Step 2: Set and Stabilize the Temperature

Once the medium is placed into the vessels, the system is heated to 37°C (±0.5°C). This temperature represents the human body and must remain stable throughout the test.

The system should be allowed enough time to reach and stabilize at this temperature before starting. Running the test too early, before stabilization, can lead to inconsistent drug release results.

Step 3: Configure the Apparatus and Rotation

In the next step, you need to set up the dissolution apparatus, usually a paddle or basket system. You can then adjust the rotation speed according to the test method.

The movement created by the apparatus makes sure the medium flows around the tablet or capsule in a controlled way. This simulates natural fluid movement in the body. Any imbalance, vibration, or incorrect speed can affect how the drug dissolves.

Step 4: Introduce the Tablet or Capsule

The tablet or capsule is then placed into the vessel. This must be done carefully to avoid breaking or altering the dosage form.

As soon as the dosage form is introduced, the timer starts. From this point onward, the drug begins to dissolve, and the test is considered active.

Step 5: Maintain Controlled Test Conditions

During the test, all conditions must remain stable. The temperature, rotation speed, and environment should not change. For instance:

• The temperature must stay at 37°C.
• Rotation must remain constant.
• External disturbances should be avoided.

Step 6: Collect Samples at Specific Intervals

Samples are taken from the vessel at predefined time points. This is done carefully so the system is not disturbed. Each sample represents how much of the drug has dissolved at the exact moment.

The sampling position, timing, and handling must remain consistent throughout the test. Any variation can lead to incorrect data.

Step 7: Analyze the Samples

The collected samples are then analyzed using laboratory instruments such as UV spectrophotometers or HPLC systems. This step determines the concentration of the drug in each sample.

The results are then converted into a percentage of drug dissolved, which forms the basis for evaluation.

Step 8: Generate and Evaluate Results

In this step, the data is plotted to create a dissolution profile. This shows how the drug is released over time.

Finally, the results are compared against predefined acceptance criteria. If the product meets these criteria, it passes the test. However, if it doesn’t, it fails and cannot be released without further investigation.

Types of Dissolution Apparatus (USP Methods)

The dissolution test for tablets and capsules is performed using standardized equipment. These methods guarantee that results are consistent, comparable, and acceptable for regulatory purposes.

К ним относятся:

1. Apparatus 1 (Basket Method)

In this method, the tablet or capsule is placed inside a small wire mesh basket that rotates within the dissolution medium. The basket holds the dosage form in place while allowing the liquid to flow through it.

The rotation creates a controlled environment where the drug dissolves gradually into the medium. This method is especially useful for капсулы that may float and dosage forms that need to stay contained during testing.

2. Apparatus 2 (Paddle Method)

The paddle method is the most widely used approach. In this setup, the tablet or capsule is placed directly at the bottom of the vessel, and a rotating paddle stirs the medium above it.

As the paddle rotates, it creates a flow pattern that helps the drug dissolve evenly into the liquid. This method is commonly used for immediate-release tablets and standard capsule formulations.

Common Problems in Dissolution Testing

Even when the method is validated, dissolution testing can produce unreliable results if small details are missed. Most issues come from setup errors, poor control of conditions, or equipment that is not properly maintained.

These problems are as follows.

1. Inconsistent Results

One of the most common problems is variation in results between runs or between vessels in the same test. This usually indicates that the test conditions are not fully controlled.

Inconsistency can come from differences in sample placement, timing of sampling, or slight variations in temperature and rotation. Even minor deviations can change how quickly a drug dissolves.

Another cause is variability in the dosage form itself, especially if manufacturing is not tightly controlled.

2. Equipment Issues

Dissolution equipment must operate precisely. If it does not, the entire test is affected. Problems mostly arise from misalignment, worn components, or lack of calibration. Common equipment-related issues include:

• Incorrect rotation speed due to calibration errors.
• Misaligned paddles or baskets.
• Temperature control failure.
• Vibration or instability in the system.

These issues can change fluid movement inside the vessel, which directly impacts dissolution behavior.

3. Media Errors

The dissolution medium plays a critical role in the test. If it is not prepared correctly, the results will not reflect actual drug performance.

Errors can occur if:

• The pH is outside the specified range.
• The composition of the medium is incorrect.
• Air bubbles are present due to poor degassing.
• The temperature is not properly maintained.

Since the medium simulates body conditions, any mistake in its preparation can lead to inaccurate conclusions about the drug’s behavior.

Часто задаваемые вопросы

1. How is the dissolution test performed for tablets?

A tablet is placed into a vessel containing a defined volume of dissolution medium at controlled temperature, usually close to body temperature. The paddle or basket rotates at a specified speed, and samples are withdrawn at set time points. The sample is filtered, diluted if needed, and analyzed by UV, HPLC, or another validated assay.

2. What does Q mean in a tablet dissolution test?

Q is the specified amount of active ingredient that must dissolve at a particular time point. It is not automatically 100%; it is set based on the product, drug release behavior, regulatory expectations, and validated method. In routine QC, Q helps decide whether a batch meets its dissolution specification.

3. Why do tablets fail dissolution testing?

Tablets may fail dissolution because of excessive hardness, poor wetting, over-compression, high binder level, coating defects, API particle size changes, or aging during stability. Method problems can also create false failures, including wrong RPM, incorrect pH, trapped air bubbles, poor filtration, or vessel alignment issues. A proper investigation should separate product failure from analytical or equipment error.

4. Why are air bubbles a problem in dissolution testing?

Air bubbles can attach to the tablet, capsule, basket, paddle, or vessel surface and disturb hydrodynamics. They may reduce contact between the dosage form and medium or change the agitation pattern. This can produce variable, low, or misleading dissolution results.

Build Reliable Production That Supports Accurate Testing

The dissolution test for tablets and capsules is a direct measure of how well your product will perform in real use. If the process is not controlled, the results cannot be trusted, and that puts both product quality and compliance at risk.

However, that’s not the only thing responsible for compliance. You also need the right machinery to stay GMP-compliant, and Finetech provides you with that.

We offer reliable фармацевтическое производственное и упаковочное оборудование, including filling machines, tablet presses, and more. If you want better control over product performance, the focus should start at production.

Свяжитесь с нашими специалистами сегодня to book an appointment!

Ссылки:

Что такое твердая лекарственная форма? Простое руководство для всех.

Изучите различные типы таблеток: полное руководство.

Types of Tablet Coating.

Правда о желатине: ингредиенты, источники и применение.

Понимание капсул: полное руководство по фармацевтическим капсулам.

Уведомление об авторских правах:

Вы не имеете права воспроизводить, изменять, публиковать, показывать, передавать или каким-либо образом использовать любое содержимое данного сайта, а также использовать его для создания любой базы данных без предварительного письменного разрешения компании Finetech Group. Для получения разрешения на использование контента, пожалуйста, свяжитесь с: info@pharmamachinecn.com

Отказ от ответственности:

Информация, содержащаяся в данной статье, предназначена только для общего ознакомления. Компания не гарантирует точность, актуальность, своевременность или полноту любой информации, и компания не несет ответственности за ошибки или упущения в содержании данной статьи.